Comparison between Sub-Anaesthetic Dose of Propofol and Ondansetron as Pretreatment Options in Prevention of Post Operative Nausea and Vomiting in Pregnant Females after Spinal Anaesthesia
Authors/Creators
- 1. Senior Resident Department of Obstetrics & Gynaecology Birsa Munda Medical College Shahdol, Madhya Pradesh
- 2. Senior Resident Department of Anaesthesia Shyam Shah Medical College, Rewa, Madhya Pradesh
- 3. Senior Resident Department of Critical Care Medanta the Medicity Gurugram
- 4. Senior Registrar Department of Anaesthesia Apollo Hospital, Jubilee Hills, Hyderabad, Telangana
- 5. Junior Resident Department of Anaesthesia Shyam Shah Medical College, Rewa, Madhya Pradesh
Description
Background: PONV is a common long-standing post-operative problem in anesthesia and remains a challenge, especially in obstetrics populations, and occurs more often after caesarean operations under regional anesthesia. Many anti-emetics have been studied for effectively attenuating post operative nausea and vomiting in pregnant females but there is no evident literature comparing the efficacy of sub-anaesthetic doses of propofol with ondansetron as pretreatment options on reducing the incidence and severity of post operative nausea and vomiting, this study was designed to compare efficacy of 0.5mg/kg propofol and 0.1mg/kg ondansetron intravenous pretreatment for PONV prevention in pregnant females. Aims: Aim of this study is to compare the efficacy of sub-anaesthetic dose of propofol with ondansetron in prevention of incidence and severity of post operative nausea and vomiting. Material and Methods: This prospective randomized double blind study was conducted in a tertiary hospital associated with a medical college, 60 patients undergoing elective caesarean section under spinal anaesthesia were randomly allocated to one of the two groups Group I received 0.5mg/kg of propofol and Group II 0.1mg/kg of Ondansetron, 10 minutes before completion of surgery, patients were assessed for incidence and severity of nausea and vomiting over next twenty four hours. Students t test, chi square test were used as per the requirement and a P value of <0.05 was considered statistically significant. Result: Out of 60 patients 30 were pretreated with propofol and 30 were pretreated with ondansetron 10 minutes before completion of surgery. In our study 8(26.66%) patients from propofol group developed PONV whereas only 2(6.66%) patients from ondansetron group developed PONV. In our study severity of PONV was calculated on a 3 point scale, it was observed to be 0.33 in patients belonging to propofol pretreatment group whereas it was observed to be 0.10 in ondansetron pretreatment group. Conclusion: Both groups were comparable with respect to demographic characteristics, the incidence(26.66% in group I vs. 6.66% in group II) and severity(0.33 in group I vs 0.10 in group II), of PONV was significantly reduced in ondansetron pretreatment group as compared to propofol pretreatment group, (95% confidence interval, P < 0.05).
Abstract (English)
Background: PONV is a common long-standing post-operative problem in anesthesia and remains a challenge, especially in obstetrics populations, and occurs more often after caesarean operations under regional anesthesia. Many anti-emetics have been studied for effectively attenuating post operative nausea and vomiting in pregnant females but there is no evident literature comparing the efficacy of sub-anaesthetic doses of propofol with ondansetron as pretreatment options on reducing the incidence and severity of post operative nausea and vomiting, this study was designed to compare efficacy of 0.5mg/kg propofol and 0.1mg/kg ondansetron intravenous pretreatment for PONV prevention in pregnant females. Aims: Aim of this study is to compare the efficacy of sub-anaesthetic dose of propofol with ondansetron in prevention of incidence and severity of post operative nausea and vomiting. Material and Methods: This prospective randomized double blind study was conducted in a tertiary hospital associated with a medical college, 60 patients undergoing elective caesarean section under spinal anaesthesia were randomly allocated to one of the two groups Group I received 0.5mg/kg of propofol and Group II 0.1mg/kg of Ondansetron, 10 minutes before completion of surgery, patients were assessed for incidence and severity of nausea and vomiting over next twenty four hours. Students t test, chi square test were used as per the requirement and a P value of <0.05 was considered statistically significant. Result: Out of 60 patients 30 were pretreated with propofol and 30 were pretreated with ondansetron 10 minutes before completion of surgery. In our study 8(26.66%) patients from propofol group developed PONV whereas only 2(6.66%) patients from ondansetron group developed PONV. In our study severity of PONV was calculated on a 3 point scale, it was observed to be 0.33 in patients belonging to propofol pretreatment group whereas it was observed to be 0.10 in ondansetron pretreatment group. Conclusion: Both groups were comparable with respect to demographic characteristics, the incidence(26.66% in group I vs. 6.66% in group II) and severity(0.33 in group I vs 0.10 in group II), of PONV was significantly reduced in ondansetron pretreatment group as compared to propofol pretreatment group, (95% confidence interval, P < 0.05).
Files
IJPCR,Vol15,Issue5,Article123.pdf
Files
(305.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:2d23daffd5b76917017147f598f5e8c2
|
305.2 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-05-10
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue5,Article123.pdf
- Development Status
- Active
References
- 1. C.C. Apfel, F.M. Heidrich, S. JukarRao, L. Jalota, C. Hornuss, R.P. Whelan, et al., Evidence-based analysis of risk factors for postoperative nausea and vomiting, Br. J. Anaesth. 2012;109 (5): 742–753. 2. A.T. Bantie, M. Woldeyohannes, Z.A. Ferede, B.A. Regasa, The magnitude and associated factors of nausea and vomiting after cesarean section under spinal anesthesia in Gandhi Memorial Hospital, Addis Ababa, Ethiopia. A cross-sectional study, Studies 2020; 3(7). 3. M. Jabalameli, A. Honarmand, M. Safavi, M. Chitsaz, Treatment of postoperative nausea and vomiting after spinal anesthesia for cesarean delivery: a randomized, double-blinded comparison of midazolam, ondansetron, and a combination, Adv. Biomed. Res. 2012;1. 4. Collins AS. Postoperative nausea and vomiting in adults: implications for critical care. Crit Care Nurse. 2011; 31(6):36–45 5. Chandrakantan A, Glass PSA. Multimodal therapies for postoperative nausea and vomiting and pain. Br J Anesth. 2011;107(1):i27–40. 6. Kandawasvika, T. (2011). The effect of single low dose propofol at the end of the operation in reducing postoperative nausea and vomiting (PONV) in women undergoing laparoscopic gynecological surgery at Parirenyatwa hospital. Available fromhttp://ir.uz.ac.zw/handle/10646/10 97 7. Loewen PS, Marra CA, Zed PJ. 5-HT3 receptor antagonists vs. traditional agents for the prophylaxis of postoperative nausea and vomiting. Can J Anesth. 2000;47(10):1008–18. 8. Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: Conclusions from cross-validations between two centers. Anesthesiology. 1999; 91:693– 700. 9. Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014; 118: 85 10. Scuderi PE, James RL, Harris L, Mims GR III. Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy. Anesth Analg. 2000; 91(6):1408–14. 11. Lussos SA, Bader AM, Thornhill ML, Datta S. The antiemetic efficacy and safety of prophylactic metoclopramide for elective cesarean delivery during spinal anesthesia. Reg Anesth. 1992;17(3):126–30. 12. Kumar K, Singh SI. Neuraxial opioidinduced pruritus: an update. J Anaesthesiol Clin Pharmacol. 2013;29(3):303–7 13. T.J. Gan, K.G. Belani, S. Bergese, F. Chung, P. Diemunsch, A.S. Habib, et al., Fourth consensus guidelines for the management of postoperative nauseaand vomiting, Anesth. Analg. 131 (2) (2019) 411–448. 14. Chaudhary S, Sethi AK, Motiani P, Adatia C. Pre-operative intravenous fluid therapy with crystalloids or colloids on post-operative nausea and vomiting. Indian J Med Res. 2008; 127:577–81 15. Susan Goodina, Regina Cunninghama.5-HT3-Receptor Antagonists for the Treatment of Nausea and Vomiting: A Reappraisal of Their Side-Effect Profile. The Oncologist October 2002;7:424-36. 16. Montgomery JE, Sutherland CJ, Kestin IG, Sneyd JR. Infusions of subhypnotic doses of propofol for the prevention of postoperative nausea and vomiting. Anaesthesia1996; 51: 554–7 17. Ewalenko P, Janny S, Dejonckheere M, Andry G, Wyns C. Antiemetic effect of sub hypnotic doses of propofol after thyroidectomy. Br J Anaesth. 1996; 77: 463–7. 18. El Marnissi, S., Eljaoudi, R., Bousliman, Y., & Ait El Cadi, M. Dosage des Inhibiteurs de la calcineurine en Transplantation rénale. Journal of Medical Research and Health Sciences, 2023; 6(4): 2490–2502.